{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:39:12Z","timestamp":1792539552275,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Reports"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.toxrep.2024.03.003","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T02:31:23Z","timestamp":1710469883000},"page":"356-360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Neuroleptic malignant syndrome after overdose of haloperidol \u2013 A case report"],"prefix":"10.1016","volume":"12","author":[{"given":"Nicole","family":"Kraaijvanger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Mieloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxrep.2024.03.003_bib1","unstructured":"van Waarde J.A., Beers E., Moleman P. Behandeling van maligne antipsychotica syndroom [Treatment of antipsychotic malignant syndrome]. Guideline database Federation of medical specialists. 2018. Dutch. Weblink: https:\/\/richtlijnendatabase.nl\/richtlijn\/acute_psychiatrie\/behandeling_maligne_antipsychoticasyndroom.html."},{"issue":"5","key":"10.1016\/j.toxrep.2024.03.003_bib2","first-page":"208","article-title":"Neuroleptic malignant syndrome: long-term follow-up of 20 cases","volume":"52","author":"Pope","year":"1991","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.toxrep.2024.03.003_bib3","first-page":"D6357","article-title":"Maligne antipsychoticasyndroom vroegtijdig herkennen [Early recognition of antipsychotic malignant syndrome: prevention from worse in young people with dementia]","volume":"166","author":"Gerritsen","year":"2022","journal-title":"Ned. Tijdschr. Geneeskd."},{"issue":"4","key":"10.1016\/j.toxrep.2024.03.003_bib4","article-title":"Acute ethanol intoxication: \u03b1n overlooked cause of high anion gap metabolic acidosis with a marked increase in serum osmolal gap","volume":"15","author":"Liontos","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.toxrep.2024.03.003_bib5","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5) American Psychiatric Association, 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"3","key":"10.1016\/j.toxrep.2024.03.003_bib6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/acps.13215","article-title":"The neuroleptic malignant syndrome-a systematic case series analysis focusing on therapy regimes and outcome","volume":"142","author":"Kuhlwilm","year":"2020","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.toxrep.2024.03.003_bib7","unstructured":"R.J. Gurrera, S.N. Caroff, A. Cohen, et al., An international consensus study of neuroleptic malignant syndrome diagnostic criteria using the Delphi method, The Journal of Clinical Psychiatry. 72 (2011) 1222. Copyright 2024, Physicians Postgraduate Press. Reprinted by permission."},{"key":"10.1016\/j.toxrep.2024.03.003_bib8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/1471-244X-12-214","article-title":"Antipsychotic dose escalation as a trigger for neuroleptic malignant syndrome (NMS): literature review and case series report","volume":"12","author":"Langan","year":"2012","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.toxrep.2024.03.003_bib9","unstructured":"Wijdicks E. Neuroleptic Malignant Syndrome, Uptodate, The topic was last updated in May 2022. Weblink: \u3008https:\/\/www.uptodate.com\/contents\/neuroleptic-malignant-syndrome?search=maligne%20neurolepticasyndroom&source=search_result&selectedTitle=1\u2013150&usage_type=default&display_rank=1\u3009."},{"issue":"1","key":"10.1016\/j.toxrep.2024.03.003_bib10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0025-7125(16)30278-4","article-title":"Neuroleptic malignant syndrome","volume":"77","author":"Caroff","year":"1993","journal-title":"Med Clin. North Am."},{"key":"10.1016\/j.toxrep.2024.03.003_bib11","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1192\/bjp.158.6.850","article-title":"Is the predisposition to neuroleptic malignant syndrome genetically transmitted?","volume":"158","author":"Otani","year":"1991","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.toxrep.2024.03.003_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/ajmg.b.10025","article-title":"Relationship between functional dopamine D2 and D3 receptors gene polymorphisms and neuroleptic malignant syndrome","volume":"117B","author":"Mihara","year":"2003","journal-title":"Am. J. Med Genet B Neuropsychiatr. Genet"},{"key":"10.1016\/j.toxrep.2024.03.003_bib13","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/acps.12694","article-title":"A systematic review of sex and age factors in neuroleptic malignant syndrome diagnosis frequency","volume":"135","author":"Gurrera","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.toxrep.2024.03.003_bib14","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1176\/ajp.2007.164.6.870","article-title":"Neuroleptic malignant syndrome","volume":"164","author":"Strawn","year":"2007","journal-title":"Am. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.toxrep.2024.03.003_bib15","first-page":"973","article-title":"Neuroleptic malignant syndrome","volume":"50","author":"Pileggi","year":"2016","journal-title":"Ann. Pharm."},{"issue":"8","key":"10.1016\/j.toxrep.2024.03.003_bib16","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1177\/070674371205700810","article-title":"Neuroleptic malignant syndrome-an 11-year longitudinal case-control study","volume":"57","author":"Nielsen","year":"2012","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.toxrep.2024.03.003_bib17","article-title":"Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary","volume":"2014","author":"Dosi","year":"2014","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.toxrep.2024.03.003_bib18","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/B978-0-444-64074-1.00039-2","article-title":"Neuroleptic malignant syndrome and serotonin syndrome","volume":"157","author":"Tormoehlen","year":"2018","journal-title":"Handb. Clin. Neurol."},{"issue":"9","key":"10.1016\/j.toxrep.2024.03.003_bib19","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/qjmed\/hcg109","article-title":"The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity","volume":"96","author":"Dunkley","year":"2003","journal-title":"QJM"},{"issue":"1","key":"10.1016\/j.toxrep.2024.03.003_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0447.1990.tb06439.x","article-title":"The neuroleptic malignant syndrome and its differentiation from lethal catatonia","volume":"81","author":"Fleischhacker","year":"1990","journal-title":"Acta Psychiatr. Scand."},{"issue":"6","key":"10.1016\/j.toxrep.2024.03.003_bib21","article-title":"Malignant catatonia versus neuroleptic malignant syndrome","volume":"13","author":"Desai","year":"2021","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.toxrep.2024.03.003_bib22","first-page":"CD009831","article-title":"Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorder.","author":"Dold","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.toxrep.2024.03.003_bib23","unstructured":"FDA label of haloperidol. Last revised September 2018. Weblink: https:\/\/s3-us-west-2.amazonaws.com\/drugbank\/cite_this\/attachments\/files\/000\/004\/645\/original\/FDA_Label_-_haloperidol.pdf?1562874866."},{"key":"10.1016\/j.toxrep.2024.03.003_bib24","unstructured":"Drugbank on haloperidol. Drugbank Accession Number: DB00502. Created in June, 2005. Updated in January 2024. Weblink: \u3008https:\/\/go.drugbank.com\/drugs\/DB00502\u3009."}],"container-title":["Toxicology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750024000271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750024000271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T11:42:20Z","timestamp":1718883740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214750024000271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":24,"alternative-id":["S2214750024000271"],"URL":"https:\/\/doi.org\/10.1016\/j.toxrep.2024.03.003","relation":{},"ISSN":["2214-7500"],"issn-type":[{"value":"2214-7500","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroleptic malignant syndrome after overdose of haloperidol \u2013 A case report","name":"articletitle","label":"Article Title"},{"value":"Toxicology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxrep.2024.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}